Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study
Alessia Savoldi(University of Verona), Elisa Gentilotti(University of Verona), Pasquale De Nardo(University of Verona), Mathias Smet(University of Antwerp), Roy Gusinow(University of Bonn), Enrico Gibbin(University of Verona), Surbhi Malhotra‐Kumar(University of Antwerp), Matteo Morra(University of Verona), Angelina Konnova(University of Antwerp), Akshita Gupta(University of Antwerp), Elisa Rossi(Consorzio Interuniversitario Nazionale per l'Informatica), Matilda Berkell(University of Antwerp), Jan Hasenauer(University of Bonn), Salvatore Cataudella(Consorzio Interuniversitario Nazionale per l'Informatica), Filippo Cioli Puviani, Massimo Mirandola(University of Verona), Adriana Tami(University Medical Center Groningen), Samir Kumar‐Singh(University of Antwerp), Daniele Fasan, Alessandro Castelli(University of Verona)
Cited by 4
Related Papers
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
|Acta Neuropathologica|2009|1k
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
|Nature Human Behaviour|2020|445
Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region
|The Lancet Infectious Diseases|2019|225